- Home
- CELU vs DXLG Comparison
CELU vs DXLG Comparison
Compare CELU & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- DXLG
- Stock Information
- Founded
- CELU 2016
- DXLG 1976
- Country
- CELU United States
- DXLG United States
- Employees
- CELU N/A
- DXLG N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- DXLG Clothing/Shoe/Accessory Stores
- Sector
- CELU Health Care
- DXLG Consumer Discretionary
- Exchange
- CELU Nasdaq
- DXLG Nasdaq
- Market Cap
- CELU 64.3M
- DXLG 55.4M
- IPO Year
- CELU N/A
- DXLG 1987
- Fundamental
- Price
- CELU $2.15
- DXLG $1.41
- Analyst Decision
- CELU Strong Buy
- DXLG Strong Buy
- Analyst Count
- CELU 1
- DXLG 1
- Target Price
- CELU $6.00
- DXLG $2.50
- AVG Volume (30 Days)
- CELU 136.2K
- DXLG 216.3K
- Earning Date
- CELU 08-29-2025
- DXLG 08-27-2025
- Dividend Yield
- CELU N/A
- DXLG N/A
- EPS Growth
- CELU N/A
- DXLG N/A
- EPS
- CELU N/A
- DXLG N/A
- Revenue
- CELU $44,590,000.00
- DXLG $447,744,000.00
- Revenue This Year
- CELU N/A
- DXLG N/A
- Revenue Next Year
- CELU $76.00
- DXLG $3.56
- P/E Ratio
- CELU N/A
- DXLG N/A
- Revenue Growth
- CELU 4.45
- DXLG N/A
- 52 Week Low
- CELU $1.00
- DXLG $0.90
- 52 Week High
- CELU $5.22
- DXLG $3.10
- Technical
- Relative Strength Index (RSI)
- CELU 34.61
- DXLG 56.66
- Support Level
- CELU $2.05
- DXLG $1.20
- Resistance Level
- CELU $2.41
- DXLG $1.52
- Average True Range (ATR)
- CELU 0.30
- DXLG 0.08
- MACD
- CELU -0.10
- DXLG 0.01
- Stochastic Oscillator
- CELU 6.57
- DXLG 65.62
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.